The Hindu

U.S. FDA issues seven observations to Dr. Reddys biologics manufacturing facility in Hyderabad

The company cited two previous inspections of the facility in October 2023 and September 2025 when the U.S. FDA had issued a Form 483 each with nine and five observations respectively